Prionics Acquires Pfizer Animal Health's Diagnostic Products

26-Oct-2005

Prionics AG and Pfizer Animal Health agreed that Prionics will acquire Pfizer Animal Health's diagnostic products. Terms were not disclosed.

The product line includes tests for the detection of Bovine tuberculosis (Bovigam(R)) and Paratuberculosis (Parachek(R)) in animals raised as a food source. Both diseases cause major economic damage to the farm industry and also have implications to human health.

Bovigam(R) and Parachek(R) are among the leading products in their field with significant shares in existing markets and an attractive potential for the development of new markets. Prionics will fully integrate the diagnostic tests into its product portfolio through a one year transition phase to ensure a smooth changeover.

Other news from the department research and development

Most read news

More news from our other portals

Fighting cancer: latest developments and advances

See the theme worlds for related content

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

10+ products
4 whitepaper
10+ brochures
View topic world

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

10+ products
4 whitepaper
10+ brochures